Nykode Therapeutics ASA

Last updated at 18 July 2025, 09:30 UTC from Finanstilsynet

Active Short

1.9%

Active Short Value

€10 million

Industry

Pharmaceuticals & Medical Research

Active Positions

Holder Short %
Connor, Clark & Lunn Investment Management Ltd.
June 11, 2025
0.69%
3 M€
Gsa Capital Partners Llp
April 22, 2025
1.21%
6 M€
1 day 7 days 30 days
+ 0.00 % + 0.00 % + 0.00 %

Historic Positions

Date Holder Short
2025-05-15 Connor, Clark & Lunn Investment Management Ltd. 0.70%
2025-04-09 Gsa Capital Partners Llp 1.11%
2025-04-03 Gsa Capital Partners Llp 1.00%
2025-03-27 Gsa Capital Partners Llp 0.90%
2025-02-13 Citadel Advisors Llc 0.00%
2025-02-12 Citadel Advisors Llc 0.59%
2024-12-16 Citadel Advisors Llc 0.61%
2024-12-16 Gsa Capital Partners Llp 0.81%
2024-12-11 Connor, Clark & Lunn Investment Management Ltd. 0.60%
2024-12-10 Citadel Advisors Llc 0.51%
2024-12-10 Gsa Capital Partners Llp 0.72%
2024-12-04 Connor, Clark & Lunn Investment Management Ltd. 0.52%
2024-11-23 Millennium International Management Lp 0.00%
2024-11-22 Millennium International Management Lp 0.53%
2024-11-06 Gsa Capital Partners Llp 0.60%
2024-11-01 Aqr Capital Management, Llc 0.50%
2024-09-25 Arrowstreet Capital, L.P. 0.51%
2024-08-29 Pdt Partners, Llc 0.00%
2024-08-28 Qube Research & Technologies Limited 0.00%
2024-08-22 Qube Research & Technologies Limited 0.56%
2024-08-21 Qube Research & Technologies Limited 0.64%
2024-08-07 Qube Research & Technologies Limited 0.50%
2023-11-02 Wellington Management Company Llp 0.00%
2023-11-01 Wellington Management Company Llp 0.73%
2023-09-29 Wellington Management Company Llp 0.83%
2023-03-15 Wellington Management Company Llp 0.72%
2023-02-23 Wellington Management Company Llp 0.61%
2023-01-19 Wellington Management Company Llp 0.50%
rows per page